TipRanks
Go Ultimate55% OFF

Autolus Therapeutics (6A3A) Stock Forecast & Price Target

See the Price Targets and Ratings of:All AnalystsTop AnalystsPremium

6A3A Analyst Ratings

Strong Buy
5Ratings
5Buy0Hold0Sell
Based on 5 analysts giving stock ratings to Autolus Therapeutics in the past 3 months

6A3A Stock 12 Month Forecast

EUR 6.89▲(403.25% Upside)
Based on 5 Wall Street analysts offering 12 month price targets for Autolus Therapeutics in the last 3 months. The average price target is EUR 6.89 with a high forecast of EUR 8.95 and a low forecast of EUR 4.48. The average price target represents a 403.25% change from the last price of EUR 1.37.
Highest Price TargetEUR 8.95Average Price TargetEUR 6.89Lowest Price TargetEUR 4.48

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for DE:6A3A
Price TargetFollowArticle
NeedhamEUR 8.95buy553.58%UpsideReiterated10/02/26
Wells Fargo Analyst forecast on DE:6A3AUnknown AnalystNot RankedWells FargoEUR 4.48buy226.79%UpsideReiterated10/02/26
William Blair―buy―Reiterated09/25/26
H.C. WainwrightEUR 8.95buy553.58%UpsideReiterated09/21/26
Goldman SachsEUR 4.84→EUR 5.19buy279.07%UpsideAssigned08/11/26
Mizuho SecuritiesEUR 8.95buy553.58%UpsideReiterated06/10/26
Leerink PartnersEUR 8.95→EUR 7.16buy422.86%UpsideReiterated01/13/26
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
OVIDOvid Therapeutics
REPLReplimune Group
IMUXImmunic
PTGXProtagonist Therapeutics
ESTAEstablishment Labs Holdings

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Autolus Therapeutics

3 Months
Matt Phipps
Matt PhippsWilliam Blair
Success Rate17/38 ratings generated profit
45%
Average Return
+0.77%

Copying Matt Phipps's trades and holding each position for 3 Months would result in 44.74% of your transactions generating a profit, with an average return of +0.77% per trade.

1 Year
Gil Blum
Gil BlumNeedham
Success Rate12/33 ratings generated profit
36%
Average Return
+0.57%

Copying Gil Blum's trades and holding each position for 1 Year would result in 36.36% of your transactions generating a profit, with an average return of +0.57% per trade.

2 Years
Asthika Goonewardene
Asthika GoonewardeneLeerink Partners
Success Rate7/22 ratings generated profit
32%
Average Return
-23.16%

Copying Asthika Goonewardene's trades and holding each position for 2 Years would result in 31.82% of your transactions generating a profit, with an average return of -23.16% per trade.

6A3A Analyst Recommendation Trends

05101520Nov 25Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26
Monthly rating counts for 6A3A
RatingJun 26Jul 26Aug 26Sep 26Oct 26
Strong Buy79993
Buy23442
Hold00000
Sell00000
Strong Sell00000
total91213135

In the current month, 6A3A has received 5 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. 6A3A average Analyst price target in the past 3 months is 6.89.

6A3A Financial Forecast

EUR -2EUR -1.5EUR -1EUR -0.5EUR 0Q4 2025Q2 2026Q3 2026
HighEUR -0.09
ConsensusEUR -0.15
LowEUR -0.19

6A3A Earnings Forecast

Next quarter’s earnings estimate for 6A3A is -EUR 0.15 with a range of -EUR 0.19 to -EUR 0.09. The previous quarter’s EPS was -EUR 0.13. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.

EUR 18.9MEUR 24.4MEUR 30MEUR 35.6MEUR 41.2MQ4 2025Q2 2026Q3 2026
HighEUR 41.2M
ConsensusEUR 35.4M
LowEUR 32.8M

6A3A Sales Forecast

Next quarter’s sales forecast for 6A3A is EUR 35.40M with a range of EUR 32.77M to EUR 41.19M. The previous quarter’s sales results were EUR 40.98M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

6A3A Stock Forecast FAQ

What is DE:6A3A’s average 12-month price target, according to analysts?
Based on analyst ratings, Autolus Therapeutics’s 12-month average price target is €6.89.
What is DE:6A3A’s upside potential, based on the analysts’ average price target?
Autolus Therapeutics has 403.25% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Autolus Therapeutics a Buy, Sell or Hold?
Autolus Therapeutics has a consensus rating of Strong Buy, which is based on 5 buy ratings, 0 hold ratings and 0 sell ratings.
What is Autolus Therapeutics’s share price target?
The average share price target for Autolus Therapeutics is €6.89. This is based on 5 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is €8.95, and the lowest forecast is €4.48. The average share price target represents a 403.25% increase from the current price of €1.37.
What do analysts say about Autolus Therapeutics?
Autolus Therapeutics’s analyst rating consensus is a Strong Buy. This is based on the ratings of 5 Wall Street analysts.
How can I buy shares of Autolus Therapeutics?
To buy shares of DE:6A3A, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.